Millendo Therapeutics Inc (MLND)

1.06  -0.06 (-5.36%)

After market: 1.06 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Millendo Therapeutics Inc

NASDAQ:MLND (6/25/2021, 7:00:01 PM)

After market: 1.06 0 (0%)

1.06

-0.06 (-5.36%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap20.19M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

MLND Daily chart

Company Profile

Millendo Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Ann Arbor, Michigan. The company went IPO on 2012-10-04. Tempest Therapeutics, Inc.(Tempest), formerly Millendo Therapeutics, Inc., is a clinical-stage oncology company. The firm is focused on developing therapeutics that combine both targeted and immune-mediated mechanisms to treat a wide range of tumors. The Company’s two clinical programs are TPST-1495 and TPST-1120. The firm's both TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study both agents as monotherapies and in combination with other approved agents. Tempest is also developing an orally-available inhibitor of TREX-1 designed to activate cGAS/STING pathway, an innate immune response pathway important for the development of anti-tumor immunity.

Company Info

Millendo Therapeutics Inc

Ann Arbor MICHIGAN 48104

P: 17348459000.0

CEO: Louis Arcudi

MLND News

News Image3 years ago - Tempest TherapeuticsTempest and Millendo Announce Stockholder Approval of Merger

Tempest to Trade on Nasdaq Public Markets Under Ticker “TPST”

News Image3 years ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COHR, SNX, PFBI, MLND; Shareholders are Encouraged to Contact the Firm
News Image3 years ago - WeissLaw LLPSHAREHOLDER ALERT: WeissLaw LLP Reminds MLND, DISCA, FOE and MSGN Shareholders About Its Ongoing Investigations
News Image3 years ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, FMBI, SWN, ENVB, MLND; Shareholders are Encouraged to Contact the Firm
News Image3 years ago - WeissLaw LLPSHAREHOLDER ALERT: WeissLaw LLP Reminds STAY, MLND, MSGN, and MX Shareholders About Its Ongoing Investigations
News Image3 years ago - Halper Sadeh LLP SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FOE, MX, DISCA, MLND; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 25, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Ferro Corporation (NYSE:FOE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Prince International Corporation for $22.00 per share in cash. If you are a Ferro shareholder, click here to learn more about your rights and

MLND Twits

Here you can normally see the latest stock twits on MLND, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example